Magnetic resonance imaging of small bowel crohn’s disease
DOI:
https://doi.org/10.20344/amp.62Abstract
Crohn’s disease (CD) is a chronic relapsing inflammatory disease of the gastrointestinal tract, which mostly affects young patients. Imaging techniques form a very important part for the evaluation of CD and for monitoring disease progression or response to therapy. Currently, imaging of CD is increasingly being performed by cross-sectional modalities, i.e. multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI), since these techniques allow for simultaneous visualization of luminal, mural and extraintestinal disease extension. MR enterography has the potential to safely and noninvasively accomplish the imaging needs of patients with Crohn disease without exposing them to ionizing radiation. The new imaging paradigm should contemplate patient safety as a very important aspect when assessing the role of an imaging modality in comparison with others. For this reason, MRI may be the preferred modality for evaluation of small bowel disease, especially in young patients in the setting of CD, considering that the majority will undergo frequent repeat studies. Also, the information on disease activity is not matched by any other imaging method. In this review article, the authors discuss the essential aspects of MR evaluation of CD, including protocol and imaging findings, also referring the advantages over other radiological studies, concerning safety, accuracy and potential importance for therapeutic approach.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.